$336.77 -0.1% vs prev close
SYK Stock Price vs. AI Score Data gathered: March 13
3M 4.7%

AI Stock Analysis - Stryker (SYK)

Analysis generated November 25, 2025.

Stryker Corporation, headquartered in Kalamazoo, Michigan, is one of the world’s leading medical technology companies. It offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Stryker's growth strategy revolves around its commitment to innovation, quality manufacturing, and effective partnerships with healthcare leaders across the globe.

Read full AI stock Analysis

Stock Alerts - Stryker (SYK)

company logo Stryker | March 13
Reddit mentions are up by 1067% in the last 24h.
company logo Stryker | March 10
Employee Rating is up by 2.5% over the last month.
company logo Stryker | February 20
Thomas H. Kean (member of U.S. congress) is selling shares
company logo Stryker | February 7
Insider Alert: STRYKER RONDA E is selling shares

Download our app to get future alerts delivered in real-time.

About Stryker

Stryker Corporation operates as a medical technology company. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.


Stryker
Price $336.77
Target Price Sign up
Volume 1,842,959
Market Cap $129B
Year Range $336.77 - $401.61
Dividend Yield 1.01%
PE Ratio 40.14
Analyst Rating 82% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q4 '257.17B2.49B4.68B849M1.71B4.470
Q3 '256.06B2.21B3.85B859M1.36B3.190
Q2 '256.02B2.27B3.75B884M1.47B3.130
Q1 '255.87B2.19B3.68B654M1.04B2.840
Q4 '246.44B2.45B3.99B546M792M4.010

Insider Transactions View All

STRYKER RONDA E filed to sell 2,453,092 shares at $361.5.
February 6 '26
STRYKER RONDA E filed to sell 2,207,331 shares at $367.
February 6 '26
STRYKER RONDA E filed to sell 2,213,673 shares at $366.4.
February 6 '26
STRYKER RONDA E filed to sell 2,288,598 shares at $364.3.
February 6 '26
STRYKER RONDA E filed to sell 2,236,824 shares at $365.3.
February 6 '26

Congress Trading View All

Politician Filing Date Type Size
Thomas H. Kean
Feb 20, 26 Sell $15K - $50K
Thomas H. Kean
Dec 19, 25 Sell $15K - $50K
Thomas H. Kean
Oct 15, 25 Sell $15K - $50K

FAQ - Stryker

The Market Cap of Stryker is $129B.

As of today, Stryker's PE (Price to Earnings) ratio is 40.14.

Currently, the price of one share of Stryker stock is $336.77.

The SYK stock price chart above provides a comprehensive visual representation of Stryker's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Stryker shares. Our platform offers an up-to-date SYK stock price chart, along with technical data analysis and alternative data insights.

Yes, Stryker (SYK) offers dividends to its shareholders, with a dividend yield of 1.01%. This dividend yield represents Stryker's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Stryker in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

Some of the similar stocks of Stryker are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Becton Dickinson and Co.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.

Chat with AltIndex AI

👋 Welcome to AltIndex AI Chat!

Ask about:
  • Top Stocks
  • AI score insights
  • Trending investment opportunities
  • How to use AltIndex
You need to log in to use AltIndex AI Chat.
Disclaimer: AI outputs may be incorrect. This is for informational purposes only and not a substitute for professional financial advice.